HEADER TRANSFERASE/TRANSFERASE INHIBITOR 23-MAY-12 4FC0
TITLE CRYSTAL STRUCTURE OF HUMAN KINASE DOMAIN OF B-RAF WITH A DFG-OUT
TITLE 2 INHIBITOR
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE B-RAF;
COMPND 3 CHAIN: A, B;
COMPND 4 FRAGMENT: KINASE DOMAIN (UNP RESIDUES 445-726);
COMPND 5 SYNONYM: PROTO-ONCOGENE B-RAF, P94, V-RAF MURINE SARCOMA VIRAL
COMPND 6 ONCOGENE HOMOLOG B1;
COMPND 7 EC: 2.7.11.1;
COMPND 8 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: BRAF, BRAF1, P94, RAFB1, V-RAF MURINE SARCOMA VIRAL ONCOGENE
SOURCE 6 HOMOLOG B1;
SOURCE 7 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA;
SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108;
SOURCE 9 EXPRESSION_SYSTEM_STRAIN: SF9;
SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS;
SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PFASTBAC
KEYWDS HUMAN SERINE/THERONINE PROTEIN KINASE, KINASE DRUG COMPLEX,
KEYWDS 2 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR J.K.YANO,K.AERTGEERTS
REVDAT 2 28-FEB-24 4FC0 1 REMARK SEQADV
REVDAT 1 08-JAN-14 4FC0 0
JRNL AUTH M.HIROSE,M.OKANIWA,T.MIYAZAKI,T.IMADA,T.OHASHI,Y.TANAKA,
JRNL AUTH 2 T.ARITA,M.YABUKI,T.KAWAMOTO,S.TSUTSUMI,A.SUMITA,T.TAKAGI,
JRNL AUTH 3 B.C.SANG,J.YANO,K.AERTGEERTS,S.YOSHIDA,T.ISHIKAWA
JRNL TITL DESIGN AND SYNTHESIS OF NOVEL DFG-OUT RAF/VASCULAR
JRNL TITL 2 ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (VEGFR2) INHIBITORS: 3.
JRNL TITL 3 EVALUATION OF 5-AMINO-LINKED THIAZOLO[5,4-D]PYRIMIDINE AND
JRNL TITL 4 THIAZOLO[5,4-B]PYRIDINE DERIVATIVES.
JRNL REF BIOORG.MED.CHEM. V. 20 5600 2012
JRNL REFN ISSN 0968-0896
JRNL PMID 22883026
JRNL DOI 10.1016/J.BMC.2012.07.032
REMARK 2
REMARK 2 RESOLUTION. 2.95 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.95
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.800
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4
REMARK 3 NUMBER OF REFLECTIONS : 19355
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.200
REMARK 3 R VALUE (WORKING SET) : 0.198
REMARK 3 FREE R VALUE : 0.243
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100
REMARK 3 FREE R VALUE TEST SET COUNT : 986
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.95
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.03
REMARK 3 REFLECTION IN BIN (WORKING SET) : 1288
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.56
REMARK 3 BIN R VALUE (WORKING SET) : 0.3150
REMARK 3 BIN FREE R VALUE SET COUNT : 77
REMARK 3 BIN FREE R VALUE : 0.3450
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 4126
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 80
REMARK 3 SOLVENT ATOMS : 160
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.00
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 0.75000
REMARK 3 B22 (A**2) : 0.75000
REMARK 3 B33 (A**2) : -1.50000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 1.305
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.356
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.262
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 30.277
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.928
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.889
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4303 ; 0.008 ; 0.022
REMARK 3 BOND LENGTHS OTHERS (A): 2919 ; 0.001 ; 0.020
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5821 ; 1.079 ; 1.982
REMARK 3 BOND ANGLES OTHERS (DEGREES): 7116 ; 0.795 ; 3.000
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 512 ; 5.519 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 185 ;36.215 ;23.730
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 769 ;17.573 ;15.000
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 27 ;14.704 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 633 ; 0.059 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4687 ; 0.004 ; 0.021
REMARK 3 GENERAL PLANES OTHERS (A): 841 ; 0.001 ; 0.020
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2567 ; 0.242 ; 1.500
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1045 ; 0.034 ; 1.500
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4150 ; 0.482 ; 2.000
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1736 ; 0.748 ; 3.000
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1665 ; 1.317 ; 4.500
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 4
REMARK 3
REMARK 3 TLS GROUP : 1
REMARK 3 NUMBER OF COMPONENTS GROUP : 1
REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI
REMARK 3 RESIDUE RANGE : A 447 A 532
REMARK 3 ORIGIN FOR THE GROUP (A): 48.3840 -30.6630 13.5010
REMARK 3 T TENSOR
REMARK 3 T11: 0.2343 T22: 0.1648
REMARK 3 T33: 0.2226 T12: 0.0357
REMARK 3 T13: -0.0286 T23: 0.0096
REMARK 3 L TENSOR
REMARK 3 L11: 4.5825 L22: 3.3343
REMARK 3 L33: 6.8415 L12: -0.5454
REMARK 3 L13: -1.4207 L23: -0.2680
REMARK 3 S TENSOR
REMARK 3 S11: -0.1024 S12: -0.7083 S13: 0.1013
REMARK 3 S21: 0.4790 S22: -0.0112 S23: -0.7668
REMARK 3 S31: 0.2348 S32: 0.7576 S33: 0.1136
REMARK 3
REMARK 3 TLS GROUP : 2
REMARK 3 NUMBER OF COMPONENTS GROUP : 1
REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI
REMARK 3 RESIDUE RANGE : A 533 A 721
REMARK 3 ORIGIN FOR THE GROUP (A): 43.5380 -42.9780 -9.6000
REMARK 3 T TENSOR
REMARK 3 T11: 0.1652 T22: 0.2032
REMARK 3 T33: 0.0520 T12: 0.0274
REMARK 3 T13: -0.0005 T23: -0.0252
REMARK 3 L TENSOR
REMARK 3 L11: 1.0853 L22: 4.2279
REMARK 3 L33: 1.9698 L12: -0.8051
REMARK 3 L13: -1.3372 L23: 0.8798
REMARK 3 S TENSOR
REMARK 3 S11: 0.2172 S12: 0.2900 S13: 0.0164
REMARK 3 S21: -0.3320 S22: -0.1268 S23: 0.1223
REMARK 3 S31: -0.2539 S32: -0.1700 S33: -0.0904
REMARK 3
REMARK 3 TLS GROUP : 3
REMARK 3 NUMBER OF COMPONENTS GROUP : 1
REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI
REMARK 3 RESIDUE RANGE : B 447 B 532
REMARK 3 ORIGIN FOR THE GROUP (A): 36.0260 -11.9880 -2.7640
REMARK 3 T TENSOR
REMARK 3 T11: 0.2561 T22: 0.2152
REMARK 3 T33: 0.1828 T12: 0.0728
REMARK 3 T13: 0.0451 T23: 0.0794
REMARK 3 L TENSOR
REMARK 3 L11: 2.3434 L22: 5.4005
REMARK 3 L33: 6.2482 L12: -0.2855
REMARK 3 L13: -0.8576 L23: -0.2560
REMARK 3 S TENSOR
REMARK 3 S11: 0.0521 S12: 0.5136 S13: 0.5460
REMARK 3 S21: -0.5072 S22: 0.0099 S23: -0.3410
REMARK 3 S31: -0.5585 S32: -0.1042 S33: -0.0620
REMARK 3
REMARK 3 TLS GROUP : 4
REMARK 3 NUMBER OF COMPONENTS GROUP : 1
REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI
REMARK 3 RESIDUE RANGE : B 533 B 719
REMARK 3 ORIGIN FOR THE GROUP (A): 20.7660 -15.4060 18.9450
REMARK 3 T TENSOR
REMARK 3 T11: 0.1256 T22: 0.0787
REMARK 3 T33: 0.0350 T12: -0.0456
REMARK 3 T13: 0.0292 T23: 0.0167
REMARK 3 L TENSOR
REMARK 3 L11: 4.5082 L22: 3.2299
REMARK 3 L33: 2.4075 L12: -2.0373
REMARK 3 L13: -1.5589 L23: 1.8245
REMARK 3 S TENSOR
REMARK 3 S11: -0.0026 S12: 0.1944 S13: -0.0308
REMARK 3 S21: 0.1191 S22: 0.0502 S23: 0.1397
REMARK 3 S31: 0.1236 S32: -0.0414 S33: -0.0476
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.20
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS. U VALUES: WITH TLS ADDED
REMARK 4
REMARK 4 4FC0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-MAY-12.
REMARK 100 THE DEPOSITION ID IS D_1000072711.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 10-OCT-08
REMARK 200 TEMPERATURE (KELVIN) : 92
REMARK 200 PH : 8.3
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 23-ID-B
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.0
REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL CRYO-COOLED SI
REMARK 200 (111)
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19439
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.950
REMARK 200 RESOLUTION RANGE LOW (A) : 40.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.800
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3
REMARK 200 DATA REDUNDANCY : 4.800
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : 0.18600
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS
REMARK 200 SOFTWARE USED: NULL
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 63.96
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.41
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 7.8% PEG 8000, 0.8M LICL, 100 MM TRIS,
REMARK 280 PH 8.3, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z+1/2
REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4
REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4
REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4
REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4
REMARK 290 7555 Y,X,-Z
REMARK 290 8555 -Y,-X,-Z+1/2
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 72.98650
REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 54.98400
REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 54.98400
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 36.49325
REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 54.98400
REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 54.98400
REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 109.47975
REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 54.98400
REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 54.98400
REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 36.49325
REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 54.98400
REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 54.98400
REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 109.47975
REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 72.98650
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 2340 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 23540 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 442
REMARK 465 SER A 443
REMARK 465 ASP A 444
REMARK 465 SER A 445
REMARK 465 SER A 446
REMARK 465 LEU A 596
REMARK 465 ALA A 597
REMARK 465 THR A 598
REMARK 465 VAL A 599
REMARK 465 LYS A 600
REMARK 465 SER A 601
REMARK 465 ARG A 602
REMARK 465 TRP A 603
REMARK 465 SER A 604
REMARK 465 GLY A 605
REMARK 465 SER A 606
REMARK 465 HIS A 607
REMARK 465 GLN A 608
REMARK 465 PHE A 609
REMARK 465 GLU A 610
REMARK 465 GLN A 611
REMARK 465 LEU A 612
REMARK 465 SER A 613
REMARK 465 GLN A 627
REMARK 465 ASP A 628
REMARK 465 LYS A 629
REMARK 465 LYS A 722
REMARK 465 ILE A 723
REMARK 465 HIS A 724
REMARK 465 ARG A 725
REMARK 465 GLY B 442
REMARK 465 SER B 443
REMARK 465 ASP B 444
REMARK 465 SER B 445
REMARK 465 SER B 446
REMARK 465 SER B 604
REMARK 465 GLY B 605
REMARK 465 SER B 606
REMARK 465 HIS B 607
REMARK 465 GLN B 608
REMARK 465 PHE B 609
REMARK 465 GLU B 610
REMARK 465 GLN B 611
REMARK 465 LEU B 612
REMARK 465 SER B 613
REMARK 465 LEU B 720
REMARK 465 PRO B 721
REMARK 465 LYS B 722
REMARK 465 ILE B 723
REMARK 465 HIS B 724
REMARK 465 ARG B 725
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 PHE A 467 CG CD1 CD2 CE1 CE2 CZ
REMARK 470 LYS A 521 CG CD CE NZ
REMARK 470 LYS B 521 CG CD CE NZ
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 ARG B 700 NE - CZ - NH1 ANGL. DEV. = 4.2 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 SER A 466 -83.39 51.81
REMARK 500 ASN A 485 -80.95 -65.73
REMARK 500 ALA A 488 71.97 -108.85
REMARK 500 ILE A 542 -67.26 -96.02
REMARK 500 ARG A 574 -12.64 80.25
REMARK 500 ASP A 575 45.14 -152.42
REMARK 500 LEU A 587 -51.67 -149.85
REMARK 500 SER A 615 65.51 -107.59
REMARK 500 ARG A 625 46.40 -106.21
REMARK 500 LEU A 720 -63.19 -178.25
REMARK 500 ASN B 485 11.38 -66.41
REMARK 500 GLN B 523 132.12 -177.01
REMARK 500 ILE B 542 -70.50 -116.83
REMARK 500 ASP B 575 38.11 -156.75
REMARK 500 GLU B 585 17.55 57.49
REMARK 500 LEU B 587 -2.21 -149.46
REMARK 500 PHE B 594 51.36 -95.71
REMARK 500 LEU B 596 -8.23 75.63
REMARK 500 ARG B 700 -60.42 -29.27
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0T2 A 901
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0T2 B 901
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 3Q96 RELATED DB: PDB
REMARK 900 RELATED ID: 4DBN RELATED DB: PDB
DBREF 4FC0 A 444 725 UNP P15056 BRAF_HUMAN 445 726
DBREF 4FC0 B 444 725 UNP P15056 BRAF_HUMAN 445 726
SEQADV 4FC0 GLY A 442 UNP P15056 EXPRESSION TAG
SEQADV 4FC0 SER A 443 UNP P15056 EXPRESSION TAG
SEQADV 4FC0 GLY B 442 UNP P15056 EXPRESSION TAG
SEQADV 4FC0 SER B 443 UNP P15056 EXPRESSION TAG
SEQRES 1 A 284 GLY SER ASP SER SER ASP ASP TRP GLU ILE PRO ASP GLY
SEQRES 2 A 284 GLN ILE THR VAL GLY GLN ARG ILE GLY SER GLY SER PHE
SEQRES 3 A 284 GLY THR VAL TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA
SEQRES 4 A 284 VAL LYS MET LEU ASN VAL THR ALA PRO THR PRO GLN GLN
SEQRES 5 A 284 LEU GLN ALA PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS
SEQRES 6 A 284 THR ARG HIS VAL ASN ILE LEU LEU PHE MET GLY TYR SER
SEQRES 7 A 284 THR LYS PRO GLN LEU ALA ILE VAL THR GLN TRP CYS GLU
SEQRES 8 A 284 GLY SER SER LEU TYR HIS HIS LEU HIS ILE ILE GLU THR
SEQRES 9 A 284 LYS PHE GLU MET ILE LYS LEU ILE ASP ILE ALA ARG GLN
SEQRES 10 A 284 THR ALA GLN GLY MET ASP TYR LEU HIS ALA LYS SER ILE
SEQRES 11 A 284 ILE HIS ARG ASP LEU LYS SER ASN ASN ILE PHE LEU HIS
SEQRES 12 A 284 GLU ASP LEU THR VAL LYS ILE GLY ASP PHE GLY LEU ALA
SEQRES 13 A 284 THR VAL LYS SER ARG TRP SER GLY SER HIS GLN PHE GLU
SEQRES 14 A 284 GLN LEU SER GLY SER ILE LEU TRP MET ALA PRO GLU VAL
SEQRES 15 A 284 ILE ARG MET GLN ASP LYS ASN PRO TYR SER PHE GLN SER
SEQRES 16 A 284 ASP VAL TYR ALA PHE GLY ILE VAL LEU TYR GLU LEU MET
SEQRES 17 A 284 THR GLY GLN LEU PRO TYR SER ASN ILE ASN ASN ARG ASP
SEQRES 18 A 284 GLN ILE ILE PHE MET VAL GLY ARG GLY TYR LEU SER PRO
SEQRES 19 A 284 ASP LEU SER LYS VAL ARG SER ASN CYS PRO LYS ALA MET
SEQRES 20 A 284 LYS ARG LEU MET ALA GLU CYS LEU LYS LYS LYS ARG ASP
SEQRES 21 A 284 GLU ARG PRO LEU PHE PRO GLN ILE LEU ALA SER ILE GLU
SEQRES 22 A 284 LEU LEU ALA ARG SER LEU PRO LYS ILE HIS ARG
SEQRES 1 B 284 GLY SER ASP SER SER ASP ASP TRP GLU ILE PRO ASP GLY
SEQRES 2 B 284 GLN ILE THR VAL GLY GLN ARG ILE GLY SER GLY SER PHE
SEQRES 3 B 284 GLY THR VAL TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA
SEQRES 4 B 284 VAL LYS MET LEU ASN VAL THR ALA PRO THR PRO GLN GLN
SEQRES 5 B 284 LEU GLN ALA PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS
SEQRES 6 B 284 THR ARG HIS VAL ASN ILE LEU LEU PHE MET GLY TYR SER
SEQRES 7 B 284 THR LYS PRO GLN LEU ALA ILE VAL THR GLN TRP CYS GLU
SEQRES 8 B 284 GLY SER SER LEU TYR HIS HIS LEU HIS ILE ILE GLU THR
SEQRES 9 B 284 LYS PHE GLU MET ILE LYS LEU ILE ASP ILE ALA ARG GLN
SEQRES 10 B 284 THR ALA GLN GLY MET ASP TYR LEU HIS ALA LYS SER ILE
SEQRES 11 B 284 ILE HIS ARG ASP LEU LYS SER ASN ASN ILE PHE LEU HIS
SEQRES 12 B 284 GLU ASP LEU THR VAL LYS ILE GLY ASP PHE GLY LEU ALA
SEQRES 13 B 284 THR VAL LYS SER ARG TRP SER GLY SER HIS GLN PHE GLU
SEQRES 14 B 284 GLN LEU SER GLY SER ILE LEU TRP MET ALA PRO GLU VAL
SEQRES 15 B 284 ILE ARG MET GLN ASP LYS ASN PRO TYR SER PHE GLN SER
SEQRES 16 B 284 ASP VAL TYR ALA PHE GLY ILE VAL LEU TYR GLU LEU MET
SEQRES 17 B 284 THR GLY GLN LEU PRO TYR SER ASN ILE ASN ASN ARG ASP
SEQRES 18 B 284 GLN ILE ILE PHE MET VAL GLY ARG GLY TYR LEU SER PRO
SEQRES 19 B 284 ASP LEU SER LYS VAL ARG SER ASN CYS PRO LYS ALA MET
SEQRES 20 B 284 LYS ARG LEU MET ALA GLU CYS LEU LYS LYS LYS ARG ASP
SEQRES 21 B 284 GLU ARG PRO LEU PHE PRO GLN ILE LEU ALA SER ILE GLU
SEQRES 22 B 284 LEU LEU ALA ARG SER LEU PRO LYS ILE HIS ARG
HET 0T2 A 901 40
HET 0T2 B 901 40
HETNAM 0T2 2-CHLORO-3-[(2-CYANOPROPAN-2-YL)OXY]-N-{5-[{2-
HETNAM 2 0T2 [(CYCLOPROPYLCARBONYL)AMINO][1,3]THIAZOLO[5,4-
HETNAM 3 0T2 B]PYRIDIN-5-YL}(METHYL)AMINO]-2-FLUOROPHENYL}BENZAMIDE
FORMUL 3 0T2 2(C28 H24 CL F N6 O3 S)
FORMUL 5 HOH *160(H2 O)
HELIX 1 1 THR A 490 ARG A 505 1 16
HELIX 2 2 LEU A 536 ILE A 542 1 7
HELIX 3 3 GLU A 548 LYS A 569 1 22
HELIX 4 4 LYS A 577 ASN A 579 5 3
HELIX 5 5 SER A 615 MET A 619 5 5
HELIX 6 6 ALA A 620 ARG A 625 1 6
HELIX 7 7 SER A 633 GLY A 651 1 19
HELIX 8 8 ASN A 660 ARG A 670 1 11
HELIX 9 9 ASP A 676 VAL A 680 5 5
HELIX 10 10 PRO A 685 LEU A 696 1 12
HELIX 11 11 LYS A 699 ARG A 703 5 5
HELIX 12 12 LEU A 705 SER A 719 1 15
HELIX 13 13 THR B 490 ARG B 505 1 16
HELIX 14 14 LEU B 536 ILE B 542 1 7
HELIX 15 15 GLU B 548 LYS B 569 1 22
HELIX 16 16 LYS B 577 ASN B 579 5 3
HELIX 17 17 SER B 615 MET B 619 5 5
HELIX 18 18 ALA B 620 MET B 626 1 7
HELIX 19 19 SER B 633 GLY B 651 1 19
HELIX 20 20 ASN B 660 ARG B 670 1 11
HELIX 21 21 ASP B 676 VAL B 680 5 5
HELIX 22 22 PRO B 685 LEU B 696 1 12
HELIX 23 23 LYS B 699 ARG B 703 5 5
HELIX 24 24 LEU B 705 ARG B 718 1 14
SHEET 1 A 5 THR A 457 GLY A 465 0
SHEET 2 A 5 GLY A 468 LYS A 474 -1 O VAL A 470 N GLY A 463
SHEET 3 A 5 ASP A 478 LEU A 484 -1 O MET A 483 N THR A 469
SHEET 4 A 5 ALA A 525 GLN A 529 -1 O ILE A 526 N LYS A 482
SHEET 5 A 5 PHE A 515 SER A 519 -1 N GLY A 517 O VAL A 527
SHEET 1 B 3 GLY A 533 SER A 535 0
SHEET 2 B 3 ILE A 581 HIS A 584 -1 O LEU A 583 N SER A 534
SHEET 3 B 3 THR A 588 ILE A 591 -1 O THR A 588 N HIS A 584
SHEET 1 C 5 THR B 457 GLY B 465 0
SHEET 2 C 5 GLY B 468 LYS B 474 -1 O GLY B 468 N GLY B 465
SHEET 3 C 5 ASP B 478 MET B 483 -1 O VAL B 479 N GLY B 473
SHEET 4 C 5 ALA B 525 GLN B 529 -1 O ILE B 526 N LYS B 482
SHEET 5 C 5 PHE B 515 SER B 519 -1 N GLY B 517 O VAL B 527
SHEET 1 D 3 GLY B 533 SER B 535 0
SHEET 2 D 3 ILE B 581 HIS B 584 -1 O LEU B 583 N SER B 534
SHEET 3 D 3 THR B 588 ILE B 591 -1 O LYS B 590 N PHE B 582
CISPEP 1 LYS A 521 PRO A 522 0 0.79
SITE 1 AC1 17 ALA A 480 LYS A 482 GLU A 500 VAL A 503
SITE 2 AC1 17 LEU A 504 LEU A 513 ILE A 526 THR A 528
SITE 3 AC1 17 GLN A 529 TRP A 530 CYS A 531 GLY A 533
SITE 4 AC1 17 ILE A 591 GLY A 592 ASP A 593 PHE A 594
SITE 5 AC1 17 HOH A1034
SITE 1 AC2 20 VAL B 470 ALA B 480 LYS B 482 GLU B 500
SITE 2 AC2 20 VAL B 503 LEU B 504 LEU B 513 ILE B 526
SITE 3 AC2 20 THR B 528 GLN B 529 TRP B 530 CYS B 531
SITE 4 AC2 20 GLY B 533 LEU B 566 HIS B 573 PHE B 582
SITE 5 AC2 20 GLY B 592 ASP B 593 PHE B 594 ALA B 597
CRYST1 109.968 109.968 145.973 90.00 90.00 90.00 P 41 21 2 16
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.009094 0.000000 0.000000 0.00000
SCALE2 0.000000 0.009094 0.000000 0.00000
SCALE3 0.000000 0.000000 0.006851 0.00000